Bone morphogenetic protein-6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophages

Cancer Science

Volumn 104, Issue 8, 2013, Pages 1027-1032

  Lee, Geun Taek ^a   Jung, Yeon Suk ^a   Ha, Yun Sok ^a,b   Kim, Jeong Hyun ^a,c   Kim, Wun Jae ^b   Kim, Isaac Y ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Chungbuk National University College of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTINEOPLASTIC AGENT; BICALUTAMIDE; BONE MORPHOGENETIC PROTEIN 6; CLODRONIC ACID; ENZALUTAMIDE; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LDN 193189; LIPOSOME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PICTILISIB; STAT3 PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CASTRATION RESISTANT PROSTATE CANCER; CELL COUNT; COCULTURE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION;

EID: 84881102375     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12206     Document Type: Article

References (21)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Kim IY, Lee DH, Lee DK et al. Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene 2004; 23: 7651-9.
3. Autzen P, Robson CN, Bjartell A et al. Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 1998; 78: 1219-23.
4. Ide H, Yoshida T, Matsumoto N et al. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 1997; 57: 5022-7.
5. Brubaker KD, Corey E, Brown LG, Vessella RL. Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 2004; 91: 151-60.
6. Lee GT, Kwon SJ, Lee JH et al. Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways. J Biol Chem 2010; 285: 39401-8.
7. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 2000; 60: 5857-61.
8. Chun JY, Nadiminty N, Dutt S et al. Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res 2009; 15: 4815-22.
9. Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Prostate 2007; 67: 764-73.
10. Zhu P, Baek SH, Bourk EM et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 2006; 124: 615-29.
11. Jiao J, Wang S, Qiao R et al. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res 2007; 67: 6083-91.
12. Jeet V, Ow K, Doherty E, Curley B, Russell PJ, Khatri A. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer. Prostate 2008; 68: 548-62.
13. Tamada H, Kitazawa R, Gohji K, Kitazawa S. Epigenetic regulation of human bone morphogenetic protein 6 gene expression in prostate cancer. J Bone Miner Res 2001; 16: 487-96.
14. Eulenfeld R, Dittrich A, Khouri C et al. Interleukin-6 signalling: more than Jaks and STATs. Eur J Cell Biol 2012; 91: 486-95.
15. Lee GT, Kwon SJ, Lee JH et al. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop. Prostate 2011; 71: 1525-37.
16. Qiu T, Grizzle WE, Oelschlager DK, Shen X, Cao X. Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1. EMBO J 2007; 26: 346-57.
17. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010; 464: 302-5.
18. Hong JH, Lee GT, Lee JH et al. Effect of bone morphogenetic protein-6 on macrophages. Immunology 2009; 128: e442-50.
19. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 2000; 17: 445-51.
20. Spiotto MT, Chung TD. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells. Prostate 2000; 42: 186-95.
21. Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocr Relat Cancer 2007; 14: 531-47.